Cecilia Bergonzini

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells

Stella Cascioferro, Giovanna Li Petri, Barbara Parrino et al. · European Journal of Medicinal Chemistry · 2020 · 65 citations · Full text

Pancreatic Cancer, Antiproliferative Activity, Medicine +5

ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells

Cecilia Bergonzini, Alessandro Gregori, Tessa M. S. Hagens et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 28 citations · Full text

Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)

Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula et al. · Cancers · 2023 · 27 citations · Full text

Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer?

Cecilia Bergonzini, Alessandro Leonetti, Marcello Tiseo et al. · Expert Opinion on Pharmacotherapy · 2020 · 25 citations · Full text

Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile

Camilla Pecoraro, Daniela Carbone, Fabio Scianò et al. · Journal of drug targeting · 2024 · 10 citations